Results 211 to 220 of about 10,242 (284)

Botulinum neurotoxins: A distinct subclass of SNARE-Cleaving endopeptidases. [PDF]

Anaerobe
Pellett S.
europepmc   +1 more source

The Relationship Between the Gross Motor Function Classification System, Functional Mobility Scale, Observational Gait Scale, and the Amsterdam Gait Classification in Children with Cerebral Palsy During Long-Term Treatment with Botulinum Toxin Injections and Combined Integrated, Intensive Rehabilitation. [PDF]

Toxins (Basel)
Pyrzanowska W, Chrościńska-Krawczyk M, Dursun N, Bonikowski M.   +3 more
europepmc   +1 more source

Highly Cited Research on Botulinum Toxin: A Bibliometric Analysis of Clinical Trends, Influential Evidence, and Healthcare-Relevant Applications (1991-2022). [PDF]

Healthcare (Basel)
Ho YS, de Sousa Mendes LA, De la Torre Canales G, Christidis N.   +3 more
europepmc   +1 more source

Botulinum Toxin Treatment Can Enlarge Eye Appearance in Asian Patients and Improves Social and Emotional Attributes. [PDF]

Toxins (Basel)
de Maio M, Kato K, Sato M, Horiuchi Y, Toyama T, Imaizumi A, Ishii H.   +6 more
europepmc   +1 more source

Botulinum Toxin Type A Injections in the Bladder Wall-An Effective Treatment for Urinary Incontinence with Low Long-Term Adherence. [PDF]

Toxins (Basel)
Cruz F, Michel MC, Igawa Y.
europepmc   +1 more source

Beyond Wrinkle Efficacy: Toward a Broader Assessment of Longitudinal Compatibility in Routine Upper-Face Aesthetic BoNT-A. [PDF]

Toxins (Basel)
Armenti AF.
europepmc   +1 more source

Clostridium botulinum Type-E Toxin

Nippon Saikingaku Zasshi, 1968
openaire   +3 more sources

Exploratory Use of Proximal Cryoneurolysis and Distal Botulinum Toxin Type A for Upper-Limb Spasticity: A Case Report with Scoping Review. [PDF]

Toxins (Basel)
Luigi DL, Bruno M, Maria FA, Francesco F, Vincenzo P, Nicola P, Carmine D.   +6 more
europepmc   +1 more source

Efficacy and Safety of IncobotulinumtoxinA for the Treatment of Blepharospasm: A Multicenter, Phase 3 Study in Japan. [PDF]

Toxins (Basel)
Goseki T, Mochizuki Y, Masuda A, Kiyosawa M, Miyamoto R, Wakakura M, Yamagami A, Mukai Y, Shinkai A, Iijima M, Baba K, Chuman H, Hashizuka M, Tateishi S, Kimura A.   +14 more
europepmc   +1 more source

Systematic Review and Meta-Analysis of Secondary Treatment Failure and Immunogenicity with Botulinum Neurotoxin A in Multiple Indications-Comment on Recommending IncobotulinumtoxinA as First-Line to Prevent Secondary Treatment Failure [Letter]. [PDF]

Eur J Neurol
Magacho-Vieira FN.
europepmc   +1 more source